# Contact Safe TB-500: Editorial Inquiries About the Research Digest

> Contact Safe TB-500 with editorial inquiries or corrections about the cited TB-500 and thymosin beta-4 research digest. We do not provide medical advice or sell any product.

Editorial inquiries and corrections about the TB-500 research digest are welcome. Clinical questions are not something we can answer.

## Editorial inquiries

Use the form below to reach Safe TB-500 about the content of this TB-500 research digest — a correction to a citation, a study we should add, or a question about how we read a finding. We respond to editorial and sourcing matters. We are an independent editorial publisher: we do not employ clinicians, we do not provide medical advice, and we do not sell, supply, or source any product or substance.

If you are looking for dosing guidance, a prescription, or a place to obtain TB-500, this is not that resource and we cannot help with it. Our remit is the published literature and how to read it accurately. For medical questions, consult an appropriately licensed healthcare professional; for the regulatory landscape, the legal-status page summarizes the FDA-citable facts.

## What to expect

We prioritize messages that point to a specific claim and a specific source, because accuracy is the entire point of this digest. If you flag a number that does not match its citation, or a study that updates the record, that is exactly the kind of note that improves the site. We do not respond to vendor solicitations, and we do not facilitate the purchase or supply of any substance.

---

A clear-eyed digest of the TB-500 and thymosin beta-4 record, read by glow intensity — the established findings bright, the human-data gaps left dim and labeled, with no clinic behind the aurora and nothing here dispensed.